United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®
Go back to United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 497.27 -1.21 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $498.48 | 52 Week High | $164.04 | |||
| Open | $501.49 | 52 Week Low | $97.52 | |||
| Day High | $503.33 | P/E | 90.91 | |||
| Day Low | $492.59 | EPS | $5.47 | |||
| Volume | 1,184,836 | |||||
